Abstract:Although the head and neck region is recognized as the most common location for peripheral nerve sheath tumors, central involvement, particularly in the jaw bones, is quite unusual. Neurofibroma is one of the most common nerve sheath tumors occurring in the soft tissue and generally appears in neurofibromatosis 1 (NF1 or von Recklinghausen's disease). Malignant peripheral nerve sheath tumors (MPNSTs) are uncommon sarcomas that almost always arise in the soft tissue. Here, we report four cases of intraosseous p… Show more
“…Approximately 50–90% of MPNSTs are positive for S-100 protein. Occasionally, they may also express glial fibrillary acidic protein, EMA and CK expression 1 2 4 5. In the present case, histopathological features of the lesion, which included fasciculated growth pattern with alternate hypodense and hyperdense areas, and spindle cells with minimal cytological atypia, were seen infiltrating into the surrounding hard and soft tissue structures.…”
Section: Discussionmentioning
confidence: 51%
“…They mainly affect the 20–50-year-old age group and have an equal gender distribution. Radiographic presentation of intraosseous MPNST includes a complete destructive pattern with bony expansion, erosion and widening of mandibular canal/mental foramen with or without irregular destruction of surrounding bone 4 5 7. In the present case, the 30-year-old patient presented a solitary intraosseous MPNST as a well-defined radiolucent lesion in the body and ramus of the mandible.…”
Section: Discussionmentioning
confidence: 99%
“…Prognostic variables for MPNST are the size of lesion, location, stage and grade, status of margins, necrosis and use of adjuvant radiation. Among these, the status of surgical margin and history of irradiation are independent negative prognostic factors 1 5. Overall survival rate is 40–70% 4…”
We present an extremely rare case of malignant peripheral nerve sheath tumour (MPNST) in a 30-year-old woman without associated neurofibromatosis 1. The patient presented with an 8 cm×4 cm lesion extending from 46 to the retro molar region involving the ramus of the right mandible associated with regional paraesthesia. Incisional biopsy revealed spindle cells with vesicular nuclei arranged in fascicles leading to a diagnosis of spindle cell lesion. Posterior segmental mandibulectomy was performed under general anaesthesia. On excisional biopsy, a definitive diagnosis of low-grade MPNST was established on the basis of immunohistochemistry. The patient was then lost to follow-up.
“…Approximately 50–90% of MPNSTs are positive for S-100 protein. Occasionally, they may also express glial fibrillary acidic protein, EMA and CK expression 1 2 4 5. In the present case, histopathological features of the lesion, which included fasciculated growth pattern with alternate hypodense and hyperdense areas, and spindle cells with minimal cytological atypia, were seen infiltrating into the surrounding hard and soft tissue structures.…”
Section: Discussionmentioning
confidence: 51%
“…They mainly affect the 20–50-year-old age group and have an equal gender distribution. Radiographic presentation of intraosseous MPNST includes a complete destructive pattern with bony expansion, erosion and widening of mandibular canal/mental foramen with or without irregular destruction of surrounding bone 4 5 7. In the present case, the 30-year-old patient presented a solitary intraosseous MPNST as a well-defined radiolucent lesion in the body and ramus of the mandible.…”
Section: Discussionmentioning
confidence: 99%
“…Prognostic variables for MPNST are the size of lesion, location, stage and grade, status of margins, necrosis and use of adjuvant radiation. Among these, the status of surgical margin and history of irradiation are independent negative prognostic factors 1 5. Overall survival rate is 40–70% 4…”
We present an extremely rare case of malignant peripheral nerve sheath tumour (MPNST) in a 30-year-old woman without associated neurofibromatosis 1. The patient presented with an 8 cm×4 cm lesion extending from 46 to the retro molar region involving the ramus of the right mandible associated with regional paraesthesia. Incisional biopsy revealed spindle cells with vesicular nuclei arranged in fascicles leading to a diagnosis of spindle cell lesion. Posterior segmental mandibulectomy was performed under general anaesthesia. On excisional biopsy, a definitive diagnosis of low-grade MPNST was established on the basis of immunohistochemistry. The patient was then lost to follow-up.
“…Given its origin and behavior it is classified as a sarcoma [1,2]. About half the cases are diagnosed in people with neurofibromatosis; the lifetime risk for an MPNST in patients with neurofibromatosis type I is 8% to 13% [2].…”
Malignant Peripheral Nerve Sheath Tumour (MPNST) also termed as spindle cell malignancy of the peripheral nerve schwann cell or neurogenic sarcoma represents 10% of all soft tissue sarcomas. The tumour is usually found in lower extremities and only 10% to 20% of all lesions occur in head and neck region thus making it a rare entity. Central involvement, particularly in the jaw bones is quite unusual. Neurofibroma is one of the common nerve sheath tumours occurring in the soft tissues and generally appears in neurofibromatosis I (NF-I or von recklinghausen's disease). MPNST are uncommon sarcomas that almost always arise in the soft tissues. Here we report a case of intraosseous peripheral nerve sheath tumour occurring in the mandible and discuss the surgical management with adjuvant and neoadjuvant treatment plan.
“…19) Ten cases of intraosseous neurofibroma showed evidence of NF. 5,7,9,13,15,24,26) However, the present case did not satisfy the criteria for NF, and was regarded as the solitary type of neurofibroma.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.